Research Directory

Why synthetic gene promoters matter

Read more

Advancing investment across Europe

Read more

Exploring novel payloads for antibody-drug conjugates

Read more

Epigenetic modulation in pulmonary disease

Read more

How argenx reached Nasdaq as a small European biotech

Read more

EU pharma reform meets US MFN pricing

Read more

Natural history studies underpin clinical research

Read more

Redefining drug discovery using quantum physics

Read more

Stroke research progresses towards new frontier

Read more

Interview - How Abivax delivered results for patients with ulcerative colitis

Read more